Patent · US Active

EGFR binding peptides and uses thereof

US8536113B2 · kind B2 · utility

1Cited by

9References

12Claims

0Family size

Assignee

JANSSEN BIOTECH, INC. · US

Inventors

Mohit Trikha · Village of La Jolla, US
Wang Bryan · Wyomissing, US
Frank Shi · Irvine, US
John Kehoe · Schaumburg, US

Key dates

Filing date	Dec 20, 2007
Grant date	Sep 17, 2013
Priority date	—
Expiry date	Feb 24, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Short oligopeptides are provided which are capable of binding to the epidermal growth factor receptor on the surface of human tumor cells. Methods for using the peptides as targeting moieties in more complex compositions, such as conjugates of cytoxins, and/or structures, such as liposomal structures, for the purposes of drug delivery are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.